PMDA — authorised 22 December 2022
- Marketing authorisation holder: GILEAD SCIENCES
- Status: approved
🇯🇵 Sunlenca in Japan
PMDA authorised Sunlenca on 22 December 2022
Marketing authorisation
Sunlenca in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in Japan
Frequently asked questions
Is Sunlenca approved in Japan?
Yes. PMDA authorised it on 22 December 2022.
Who is the marketing authorisation holder for Sunlenca in Japan?
GILEAD SCIENCES holds the Japanese marketing authorisation.